kentucky glp-1 gastroparesis class action stomach paralysis in Ozempic, Wegovy, Mounjaro and Other Agonists Side Effects Canadian Ozempic GLP-1 kentucky semaglutide gastrointestinal obstruction law

MASH approval: In 2025, the FDA approved Wegovy for metabolic dysfunction-associated steatohepatitis with moderate-to-advanced fibrosis but without cirrhosis

Benzyl alcohol is an aromatic alcohol that disrupts bacterial cell membrane integrity and inhibits membrane-dependent metabolic processes at 0.9% w/v concentration and providing broad-spectrum bacteriostatic activity against Gram-positive and Gram-negative contaminants without producing the higher-concentration cytotoxicity associated with bactericidal antimicrobial preservatives

Stimulants (in-competition) S7

2021;131:e148671

The more severe health risks include: An increased risk of death from cardiovascular disease